RIZVI SYED ALI-AAMIR (Chief Medical Officer) received a stock award from ROCKET PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/13/2026ACC: 0001140361-26-005409
Officer· Chief Medical Officer
Since Feb 2026
+155K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
155K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+61.96K
Price / share
—
Trade value
—
% of position
17.9%
2/11/2026
345.91K→407.87K
Total
Net shares
+61.96K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | A · Award | +61.96K | — | — | 17.9% | 345.91K | 407.87K |
| Total | +61.96K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
93.04K shares
Shares
+93.04K
Strike price
3.24
Held after
93.04K
Exercisable
—
2/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock93.04K shares | 2/11/2026 | A · Award | +93.04K | 3.24 | — | 93.04K |